Hi, what are you looking for?
Israeli Startup N-Trig which produces digital pens and chips for touchscreens, has announced that it will not be pursuing an IPO ion the Tel...
Discount Investment posted a net loss of about $184 million in the third quarter. Discount Investment Corporation (TASE: DISI), controlled by Eduardo Elsztain and...
– The Israeli content recommendation company filed confidentially, the “Wall Street Journal” reports. Outbrain Inc. has filed confidentially with the US Securities and Exchange...
– Delek CEO: A London listing will help us become a leading international energy company. – In its third quarter financial report published...
– BiondVax is exploring two options – either a conventional offering or listing American Depositary Receipts. – Universal flu vaccine developer BiondVax Pharmaceuticals...
The Israeli billionaire plans investing £200 million in developing London’s Camden Lock Village, “The Sunday Times” reports. Israel billionaire Teddy Sagi has already held...
– Israel’s NeuroDerm, which has developed a transdermal drug delivery system for the treatment of Parkinson’s disease, held a less than stellar IPO on...
– The Israeli Parkinson’s disease treatment developer is seeking $58-72 million at a company value of $290 million. – Rehovot-based NeuroDerm, which has...
NeuroDerm Ltd., an Israeli clinical stage pharmaceutical company which develops drugs for central nervous system (CNS) diseases, announced the launch of its initial public...
Endochoice, a company which produces all manner of medical devices, is planning a NASDAQ IPO for 2015 which it hopes will bring in $100...